Antipsychotic medications can cause acute dystonic reactions, which are more frequently seen with first-generation antipsychotics like haloperidol. These reactions may include dysarthria, torticollis, opisthotonus, and oculogyric crises. Atypical antipsychotics are more likely to cause diabetes mellitus and dyslipidemia, while neither typical nor atypical antipsychotics are commonly associated with osteoporosis.

Antipsychotics are a group of drugs used to treat schizophrenia, psychosis, mania, and agitation. They are divided into two categories: typical and atypical antipsychotics. The latter were developed to address the extrapyramidal side-effects associated with the first generation of typical antipsychotics. Typical antipsychotics work by blocking dopaminergic transmission in the mesolimbic pathways through dopamine D2 receptor antagonism. They are associated with extrapyramidal side-effects and hyperprolactinaemia, which are less common with atypical antipsychotics.

Extrapyramidal side-effects (EPSEs) are common with typical antipsychotics and include Parkinsonism, acute dystonia, sustained muscle contraction, akathisia, and tardive dyskinesia. The latter is a late onset of choreoathetoid movements that may be irreversible and occur in 40% of patients. The Medicines and Healthcare products Regulatory Agency has issued specific warnings when antipsychotics are used in elderly patients, including an increased risk of stroke and venous thromboembolism. Other side-effects include antimuscarinic effects, sedation, weight gain, raised prolactin, impaired glucose tolerance, neuroleptic malignant syndrome, reduced seizure threshold, and prolonged QT interval.

Trimethoprim can lead to tubular dysfunction, which can result in hyperkalemia and an increase in serum creatinine levels.

This statement is accurate, as trimethoprim can block the ENaC channel in the distal nephron, causing a type 4 hyperkalemic distal renal tubular acidosis. In this patient’s case, the use of trimethoprim, along with her regular medications, has caused acute kidney injury. It is important to avoid using trimethoprim in patients taking renin angiotensin antagonist drugs or potassium-sparing diuretics, or to monitor renal function closely.

However, the statement that hypercalcemia is a common occurrence in acute kidney injury is incorrect. Hypocalcemia is more commonly seen in this condition. Similarly, hypernatremia is not a common finding in acute kidney injury, as hyponatremia is more frequently observed. On the other hand, hyperphosphatemia is a common occurrence in acute kidney injury due to phosphate retention.

Understanding Trimethoprim: Mechanism of Action, Adverse Effects, and Use in Pregnancy

Trimethoprim is an antibiotic that is commonly used to treat urinary tract infections. Its mechanism of action involves interfering with DNA synthesis by inhibiting dihydrofolate reductase. This can potentially interact with methotrexate, which also inhibits dihydrofolate reductase. However, the use of trimethoprim can also lead to adverse effects such as myelosuppression and a transient rise in creatinine. The drug can competitively inhibit the tubular secretion of creatinine, resulting in a temporary increase that reverses upon stopping the drug. Additionally, trimethoprim can block the ENaC channel in the distal nephron, causing a hyperkalaemic distal RTA (type 4). It can also inhibit creatinine secretion, often leading to an increase in creatinine by around 40 points, but not necessarily causing AKI.

When it comes to the use of trimethoprim in pregnancy, caution is advised. The British National Formulary (BNF) warns of a teratogenic risk in the first trimester due to its folate antagonist properties. As such, manufacturers advise avoiding the use of trimethoprim during pregnancy. It is important to understand the potential risks and benefits of using this antibiotic and to consult with a healthcare provider before taking any medication.

The Mechanisms of Parathyroid Hormone in Osteoporosis Treatment

Parathyroid hormone (PTH) plays a complex role in the treatment of osteoporosis. While chronic elevation of PTH can lead to bone loss, mild elevations can help maintain trabecular bone mass. Teriparatide, a medication that mimics PTH, has been shown to increase bone mass and improve skeletal structure. However, PTH’s ability to increase bone remodelling is not beneficial in osteoporosis treatment, and chronic elevation can worsen the condition by increasing calcium resorption. PTH can activate the enzyme needed for activating vitamin D, but this is not the mechanism for its benefit in osteoporosis. Additionally, PTH can decrease calcium excretion from the kidneys, but this is also not the mechanism for its benefit in osteoporosis. Overall, PTH’s direct anabolic effect on bone is the most significant mechanism for its use in osteoporosis treatment.

Treatment Options for Organophosphate Poisoning: Atropine Therapy

Organophosphate poisoning is a serious condition that requires prompt treatment. The main therapeutic option for this condition is IV atropine therapy. Atropine works by blocking the action of acetylcholine at muscarinic receptors, which reverses the muscarinic effect seen in toxicity. This effect includes symptoms such as diarrhoea, miosis, bradycardia, bronchorrhoea, emesis, and hypotension.

While the patient may be cardiovascularly unstable, boluses of 0.9% saline are unlikely to benefit the patient significantly. The definitive treatment is with atropine and oximes. Benzodiazepines are used in the treatment of seizures, which are common in severe organophosphate poisoning. However, seizures are not an active issue in this patient, so other therapeutic agents should be prioritised.

Pralidoxime chloride is an oxime that works to reactivate the inhibited acetylcholinesterase. While it has a role in the treatment of organophosphate poisoning, it should not take priority over atropine therapy. Atropine is essential to reverse the muscarinic effects associated with toxicity, including bradycardia, which in this case is causing haemodynamic instability.

Tropicamide is a mydriatic medication that may temporarily reverse the miosis seen within this case. However, it does not treat the underlying cause. Therefore, atropine therapy remains the primary treatment option for organophosphate poisoning.

Perineal tears are a common occurrence during childbirth, and the Royal College of Obstetricians and Gynaecologists (RCOG) has developed guidelines to classify them based on their severity. First-degree tears are superficial and do not require any repair, while second-degree tears involve the perineal muscle and require suturing by a midwife or clinician. Third-degree tears involve the anal sphincter complex and require repair in theatre by a trained clinician, with subcategories based on the extent of the tear. Fourth-degree tears involve the anal sphincter complex and rectal mucosa and also require repair in theatre by a trained clinician.

There are several risk factors for perineal tears, including being a first-time mother, having a large baby, experiencing a precipitate labour, and having a shoulder dystocia or forceps delivery. It is important for healthcare providers to be aware of these risk factors and to provide appropriate care and management during childbirth to minimize the risk of perineal tears. By following the RCOG guidelines and providing timely and effective treatment, healthcare providers can help ensure the best possible outcomes for both mother and baby.

If a patient’s 2nd repeat smear at 24 months is now negative for high-risk human papillomavirus (hrHPV), the correct course of action is to return to routine recall in 3 years. This assumes that the patient had an initial abnormal smear 2 years ago, which showed hrHPV positive but normal cytology, and a repeat test at 12 months that was also hrHPV positive but cytologically normal. If the patient had still been hrHPV positive, they would have been referred for colposcopy. However, since they are now negative, they can go back to routine recall. The latest cervical screening programme does not require cytology to be performed if hrHPV is negative, so it would be inappropriate and impractical for the GP to request cytology on the sample. There is no need to repeat the smear in 4 weeks or 12 months, as transient hrHPV infection is common and self-resolves, and does not necessarily indicate a high risk of cervical cancer.

The cervical cancer screening program has evolved to include HPV testing, which allows for further risk stratification. A negative hrHPV result means a return to normal recall, while a positive result requires cytological examination. Abnormal cytology results lead to colposcopy, while normal cytology results require a repeat test at 12 months. Inadequate samples require a repeat within 3 months, and two consecutive inadequate samples lead to colposcopy. Treatment for CIN typically involves LLETZ or cryotherapy. Individuals who have been treated for CIN should be invited for a test of cure repeat cervical sample 6 months after treatment.

Osteoporosis is typically not diagnosed through blood tests, as they usually show normal values for ALP, calcium, phosphate, and PTH. Instead, a DEXA scan is used to confirm the diagnosis, with a T-score below -2.5 indicating osteoporosis. Treatment for osteoporosis typically involves oral bisphosphonates like alendronate. Blood test results showing increased ALP and calcium but normal PTH and phosphate may indicate osteolytic metastatic disease, while increased calcium, ALP, and PTH but decreased phosphate may suggest primary or tertiary hyperparathyroidism. Conversely, increased phosphate, ALP, and PTH but decreased calcium may indicate secondary hyperparathyroidism, which is often associated with chronic kidney disease.

Understanding Osteoporosis

Osteoporosis is a condition that affects the skeletal system, causing a loss of bone mass. As people age, their bone mineral density decreases, but osteoporosis is defined by the World Health Organisation as having a bone mineral density of less than 2.5 standard deviations below the young adult mean density. This condition is significant because it increases the risk of fragility fractures, which can lead to significant morbidity and mortality. In fact, around 50% of postmenopausal women will experience an osteoporotic fracture at some point.

The primary risk factors for osteoporosis are age and female gender, but other factors include corticosteroid use, smoking, alcohol consumption, low body mass index, and family history. To assess a patient’s risk of developing a fragility fracture, healthcare providers may use screening tools such as FRAX or QFracture. Additionally, patients who have sustained a fragility fracture should be evaluated for osteoporosis.

To determine a patient’s bone mineral density, a dual-energy X-ray absorptiometry (DEXA) scan is used to examine the hip and lumbar spine. If either of these areas has a T score of less than -2.5, treatment is recommended. The first-line treatment for osteoporosis is typically an oral bisphosphonate such as alendronate, although other treatments are available. Overall, osteoporosis is a significant condition that requires careful evaluation and management to prevent fragility fractures and their associated complications.

The appropriate test to be conducted on all men with erectile dysfunction is the morning testosterone level check. Checking for Chlamydia and gonorrhoeae NAAT is not necessary. Prolactin and FSH/LH should only be checked if the testosterone level is low. Referring for counseling may be considered if psychological factors are suspected, but other tests should be conducted first. Endocrinology referral is not necessary at this stage, but may be considered if the testosterone level is found to be reduced.

Erectile dysfunction (ED) is a condition where a man is unable to achieve or maintain an erection that is sufficient for sexual activity. It is not a disease but a symptom that can be caused by organic, psychogenic, or mixed factors. It is important to differentiate between the causes of ED, with gradual onset of symptoms, lack of tumescence, and normal libido favoring an organic cause, while sudden onset of symptoms, decreased libido, and major life events favoring a psychogenic cause. Risk factors for ED include cardiovascular disease, alcohol use, and certain medications.

To assess for ED, it is recommended to measure lipid and fasting glucose serum levels to calculate cardiovascular risk, as well as free testosterone levels in the morning. If free testosterone is low or borderline, further assessment may be needed. PDE-5 inhibitors, such as sildenafil, are the first-line treatment for ED and should be prescribed to all patients regardless of the cause. Vacuum erection devices can be used as an alternative for those who cannot or will not take PDE-5 inhibitors.

For young men who have always had difficulty achieving an erection, referral to urology is appropriate. Additionally, people with ED who cycle for more than three hours per week should be advised to stop. Overall, ED is a common condition that can be effectively managed with appropriate treatment.

Referral to a maternal fetal medicine unit is recommended if there are no fetal movements felt by 24 weeks. While most women feel their baby moving around 18-20 weeks, it can range from 16-24 weeks. If there is a lack of fetal movement, it could be due to various reasons, including miscarriages and stillbirth, which can be distressing. Therefore, it is important to check the fetal heartbeat and consider an ultrasound to detect any abnormalities if no fetal movements are felt by 24 weeks.

Understanding Reduced Fetal Movements

Introduction:
Reduced fetal movements can indicate fetal distress and are a response to chronic hypoxia in utero. This can lead to stillbirth and fetal growth restriction. It is believed that placental insufficiency may also be linked to reduced fetal movements.

Physiology:
Quickening is the first onset of fetal movements, which usually occurs between 18-20 weeks gestation and increases until 32 weeks gestation. Multiparous women may experience fetal movements sooner. Fetal movements should not reduce towards the end of pregnancy. There is no established definition for what constitutes reduced fetal movements, but less than 10 movements within 2 hours (in pregnancies past 28 weeks gestation) is an indication for further assessment.

Epidemiology:
Reduced fetal movements affect up to 15% of pregnancies, with 3-5% of pregnant women having recurrent presentations with RFM. Fetal movements should be established by 24 weeks gestation.

Risk factors for reduced fetal movements:
Posture, distraction, placental position, medication, fetal position, body habitus, amniotic fluid volume, and fetal size can all affect fetal movement awareness.

Investigations:
Fetal movements are usually based on maternal perception, but can also be objectively assessed using handheld Doppler or ultrasonography. Investigations are dependent on gestation at onset of RFM. If concern remains, despite normal CTG, urgent (within 24 hours) ultrasound can be used.

Prognosis:
Reduced fetal movements can represent fetal distress, but in 70% of pregnancies with a single episode of reduced fetal movement, there is no onward complication. However, between 40-55% of women who suffer from stillbirth experience reduced fetal movements prior to diagnosis. Recurrent RFM requires further investigations to consider structural or genetic fetal abnormalities.

Differential Diagnosis for a Patient with Hilar Lymphadenopathy and Erythema Nodosum

Sarcoidosis is a condition characterized by granulomas affecting multiple systems, with lung involvement being the most common. It typically affects young adults, especially females and Afro-Caribbean populations. While the cause is unknown, infections and environmental factors have been suggested. Symptoms include weight loss, fatigue, and fever, as well as erythema nodosum and anterior uveitis. Acute sarcoidosis usually resolves without treatment, while chronic sarcoidosis requires steroids and monitoring of lung function, ESR, CRP, and serum ACE levels.

Tuberculosis is a potential differential diagnosis, as it can also present with erythema nodosum and hilar lymphadenopathy. However, the absence of a fever and risk factors make it less likely.

Lung cancer is rare in young adults and typically presents as a mass or pleural effusion on X-ray.

Pneumonia is an infection of the lung parenchyma, but the absence of infective symptoms and consolidation on X-ray make it less likely.

Mesothelioma is a cancer associated with asbestos exposure and typically presents in older individuals. The absence of exposure and the patient’s age make it less likely.

Diagnosing Delirium in an Elderly Patient: UTI vs. Dementia vs. Pyelonephritis

When an 89-year-old woman presents with waxing and waning consciousness, punctuated by ‘sun-downing’, it is important to consider the possible causes of delirium. In this case, the patient has normal cognitive function but is experiencing acute global cerebral dysfunction. One possible cause of delirium in the elderly is a urinary tract infection (UTI), which can present with symptoms such as frequency and confusion.

However, it is important to rule out other potential causes of delirium, such as vascular dementia or Alzheimer’s dementia. In these conditions, cognitive decline is typically steady and progressive, whereas the patient in this case is experiencing waxing and waning consciousness. Additionally, neither of these conditions would account for the patient’s new urinary symptoms.

Another possible cause of delirium is pyelonephritis, which can present with similar symptoms to a UTI but may also include pyrexia, renal angle tenderness, and casts on urinalysis. However, in this case, the patient does not exhibit these additional symptoms.

Finally, pseudodementia is unlikely in this scenario as the patient does not exhibit any affective signs. Overall, it is important to consider all possible causes of delirium in an elderly patient and conduct a thorough evaluation to determine the underlying condition.

Management of Sickle Cell Crisis in Septic Patients Sickle cell disease is a genetic disorder that affects approximately 8-10% of the African population. When a patient with sickle cell disease presents with sepsis and tachycardia, the first step in management is to administer a fluid bolus. Intravenous fluids and analgesia, usually with opiates, are the mainstay of treatment for sickle cell crisis. However, analgesia should be managed in a step-wise manner. In addition to fluid and pain management, antibiotics should be considered to cover potential infections such as Haemophilus influenzae type b, Mycoplasma pneumoniae, and Pneumococcus. Ceftriaxone, erythromycin, and cefuroxime are examples of antibiotics that can be used. It is important to note that patients with sickle cell disease may also develop appendicitis, like any other young patient. Therefore, a surgical consult may be necessary. Despite the severity of sickle cell disease, the prognosis is good. Approximately 50% of patients survive beyond the fifth decade.

Impetigo: A Contagious Skin Infection

Impetigo is a skin infection that can be caused by either Staphylococcus aureus, Streptococcus pyogenes, or both. This condition results in the formation of yellow-crusted sores and small blisters filled with yellow fluid, which can appear anywhere on the body but are most commonly found on the face, arms, or legs. The infection is highly contagious and can be spread through direct person-to-person contact.

While impetigo does not require formal isolation, it is important to take precautions to prevent its spread. Children who are affected should stay home from school until they have received 48 hours of effective treatment. Personal hygiene, particularly hand washing and drying, should be emphasized, and children should have their own towels to prevent the spread of infection.

The correct diagnosis is Horner’s syndrome, which is characterized by ptosis and a constricted pupil. This syndrome is caused by a loss of sympathetic innervation and is likely due to a Pancoast tumor in this patient, who has a history of smoking. Other features of Horner’s syndrome include anhidrosis.

An abducens nerve palsy would cause horizontal diplopia and defective eye abduction. Lateral medullary syndrome, caused by a stroke, can also cause Horner’s syndrome but would present with additional symptoms such as ataxia and dysphagia.

An oculomotor nerve palsy would cause ptosis, a ‘down and out’ eye, and a dilated pupil. This patient only has ptosis and a constricted pupil, making oculomotor nerve palsy an incorrect diagnosis. A trochlear nerve palsy would cause vertical diplopia and limitations in eye movement.

Horner’s syndrome is a medical condition that is characterized by a set of symptoms including a small pupil (miosis), drooping of the upper eyelid (ptosis), sunken eye (enophthalmos), and loss of sweating on one side of the face (anhidrosis). The presence of heterochromia, or a difference in iris color, is often seen in cases of congenital Horner’s syndrome. Anhidrosis is also a distinguishing feature that can help differentiate between central, Preganglionic, and postganglionic lesions. Pharmacologic tests, such as the use of apraclonidine drops, can be helpful in confirming the diagnosis of Horner’s syndrome and localizing the lesion.

Central lesions, Preganglionic lesions, and postganglionic lesions can all cause Horner’s syndrome, with each type of lesion presenting with different symptoms. Central lesions can result in anhidrosis of the face, arm, and trunk, while Preganglionic lesions can cause anhidrosis of the face only. postganglionic lesions, on the other hand, do not typically result in anhidrosis.

There are many potential causes of Horner’s syndrome, including stroke, syringomyelia, multiple sclerosis, tumors, encephalitis, thyroidectomy, trauma, cervical rib, carotid artery dissection, carotid aneurysm, cavernous sinus thrombosis, and cluster headache. It is important to identify the underlying cause of Horner’s syndrome in order to determine the appropriate treatment plan.

During intercurrent illness such as diarrhoea and vomiting, it is important to suspend the use of metformin as it increases the risk of lactic acidosis. Increasing the dose of ramipril is not recommended as it may increase the risk of electrolyte disturbance while the patient is unwell. Similarly, there is no indication to double the dose of lansoprazole. Suspending ramipril is also not necessary as there is no evidence of acute electrolyte disturbance. However, reducing the dose of paracetamol to 500 mg may be considered if the patient has a low body weight.

The following table provides a summary of the typical side-effects associated with drugs used to treat diabetes mellitus. Metformin is known to cause gastrointestinal side-effects and lactic acidosis. Sulfonylureas can lead to hypoglycaemic episodes, increased appetite and weight gain, as well as the syndrome of inappropriate ADH secretion and liver dysfunction (cholestatic). Glitazones are associated with weight gain, fluid retention, liver dysfunction, and fractures. Finally, gliptins have been linked to pancreatitis.

Thyroid Carcinoma: Diagnosis and Management

Thyroid carcinoma is a type of cancer that affects the thyroid gland. There are different types of thyroid carcinoma, including follicular, papillary, anaplastic, and medullary carcinomas. The spread of the cancer varies depending on the type of carcinoma.

Follicular carcinoma spreads mainly via the bloodstream, while papillary and medullary carcinomas spread via the lymphatic system. Anaplastic cancer spreads locally. The prognosis for thyroid carcinoma is generally good, with a 90% survival rate at 10 years, especially in young people without local or metastatic spread.

The initial treatment for differentiated thyroid carcinoma, such as follicular and papillary carcinomas, is total or near-total thyroidectomy. Fine needle aspiration cytology can help differentiate between follicular adenoma and carcinoma, but a thyroid lobectomy is often necessary to confirm the diagnosis. The distinguishing features of follicular carcinoma are vascular invasion and capsule invasion, which can only be seen accurately on a full histological specimen.

Solitary thyroid nodules are best investigated using a combination of clinical examination, thyroid function tests, ultrasound and radio-isotope scans, and often FNA. Thyroid tumours can be classified as adenomas, carcinomas, and lymphomas. Carcinomas can be further sub-classified as papillary, follicular, anaplastic, or medullary.

In conclusion, the diagnosis and management of thyroid carcinoma require a multidisciplinary approach. Early detection and treatment can lead to a good prognosis, but accurate diagnosis is crucial for effective management.

If a cervical cancer screening sample is positive for high-risk strains of human papillomavirus (hrHPV) but shows no cytological abnormalities, the recommended course of action is to repeat the smear after 12 months. This is in accordance with current guidance. Colposcopy is not necessary in this case. Repeating the smear after 3 months or waiting 3 years for routine recall are also not appropriate. A repeat smear after 6 months would only be necessary after treatment for cervical intraepithelial neoplasia.

The cervical cancer screening program has evolved to include HPV testing, which allows for further risk stratification. A negative hrHPV result means a return to normal recall, while a positive result requires cytological examination. Abnormal cytology results lead to colposcopy, while normal cytology results require a repeat test at 12 months. Inadequate samples require a repeat within 3 months, and two consecutive inadequate samples lead to colposcopy. Treatment for CIN typically involves LLETZ or cryotherapy. Individuals who have been treated for CIN should be invited for a test of cure repeat cervical sample 6 months after treatment.

Differentiating Heart Murmurs: Causes and Characteristics

Heart murmurs are abnormal sounds heard during a heartbeat and can indicate underlying heart conditions. Here are some common causes and characteristics of heart murmurs:

Mitral Stenosis: This condition is most commonly caused by rheumatic fever in childhood and is rare in developed countries. Patients with mitral stenosis will have a loud S1 with an associated opening snap. However, if the mitral valve is calcified or there is severe stenosis, the opening snap may be absent and S1 soft.

Mitral Regurgitation and Ventricular Septal Defect: These conditions cause a pan-systolic murmur, which is not the correct option for differentiating heart murmurs.

Aortic Regurgitation: This condition leads to an early diastolic murmur.

Aortic Stenosis: Aortic stenosis causes an ejection systolic murmur.

Ventricular Septal Defect: As discussed, a ventricular septal defect will cause a pan-systolic murmur.

By understanding the causes and characteristics of different heart murmurs, healthcare professionals can better diagnose and treat underlying heart conditions.

The recommended course of action for a patient in early labour with a transverse foetal lie and intact amniotic sac is to offer external cephalic version (ECV) before considering other management options. Conservative management is not appropriate as it poses a high risk of maternal and foetal death. Offering an elective caesarean section is also not the first choice, as ECV should be attempted first. An immediate caesarean section is not necessary if there are no contraindications to ECV.

Understanding Transverse Lie in Foetal Presentation

Foetal lie refers to the position of the foetus in relation to the longitudinal axis of the uterus. There are three types of foetal lie: longitudinal, oblique, and transverse. Transverse lie is a rare abnormal foetal presentation where the foetal longitudinal axis is perpendicular to the long axis of the uterus. This means that the foetal head is on the lateral side of the pelvis, and the buttocks are opposite. Transverse lie is more common in women who have had previous pregnancies, have fibroids or other pelvic tumours, are pregnant with twins or triplets, have prematurity, polyhydramnios, or foetal abnormalities.

Transverse lie can be detected during routine antenatal appointments through abdominal examination or ultrasound scan. Complications of transverse lie include preterm rupture membranes, cord-prolapse, and compound presentation. Management options for transverse lie depend on the gestational age of the foetus. Before 36 weeks gestation, no management is required as most foetuses will spontaneously move into longitudinal lie during pregnancy. After 36 weeks gestation, active management through external cephalic version (ECV) or elective caesarian section is necessary. ECV should be offered to all women who would like a vaginal delivery, while caesarian section is the management for women who opt for it or if ECV is unsuccessful or contraindicated. The decision to perform caesarian section over ECV will depend on various factors, including the risks to the mother and foetus, the patient’s preference, and co-morbidities.

Management of Severe Extensive Psoriasis: Consideration of Anti-TNF Alpha Therapy

Psoriasis is a chronic inflammatory skin condition that is managed in a stepwise manner, as per the National Institute of Health Care and Excellence (NICE) guidelines. For patients with extensive psoriasis who have failed topical therapy, phototherapy, and systemic agents such as methotrexate, acitretin, and ciclosporin, or where these are not tolerated and/or contraindicated, the next step in management is to trial an anti-tumour necrosis factor (TNF) alpha, such as infliximab, etanercept, or adalimumab, given by injection.

While on anti-TNF alpha therapy, patients are at an increased risk of pneumococcal and seasonal influenzae, and should receive vaccination against these illnesses. Live vaccines should be avoided.

Repeating a further course of phototherapy may not be the most appropriate answer for patients who have already failed systemic therapy and previously showed only minimal response to phototherapy. Hydroxychloroquine is not commonly used in the management of plaque psoriasis, and rituximab is not indicated for psoriasis.

Topical tacrolimus may be used in the management of psoriasis affecting the face or flexural regions, but for patients with severe extensive psoriasis on the trunk, arms, and buttocks who have already tried and failed management with oral regimes and phototherapy, it is unlikely to be of benefit. If it has not already been used, it would not be unreasonable to trial tacrolimus for a short period. However, the next most appropriate step in management is an anti-TNF alpha.

In summary, for patients with severe extensive psoriasis who have failed previous therapies, consideration of anti-TNF alpha therapy is the next step in management, with appropriate vaccination and monitoring for potential adverse effects.